Complex Civil Litigation Law Firm

For 30 years, Faruqi & Faruqi has been dedicated to protecting the rights of shareholders, employees, and consumers through integrity, respect, and results. 

Who We Are

Attorneys for Securities, Antitrust, Consumer and Employment Law

Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action and Wage & Hour litigation.

Take Action

View our active case list and determine whether you want to participate in an action with us now
View All
Inform us of any fraud or unfair business practice using the link below
Report a Fraud
A class action suit can provide merger scrutiny to ensure you are protected
Merger Information
What we do

Investor & Shareholder Client Services

Faruqi & Faruqi strives to provide exceptional client services. These services include:
Portfolio Monitoring
We review the investment portfolios of institutional clients and prepare detailed reports.
Learn More
Corporate Governance and Regulatory Compliance
We monitor changes in the law to protect shareholders from corporate non-compliance.
Learn More
Case Evaluation
We perform complex damage analyses to evaluate the merit of clients’ cases.
Learn More
Legal Practice Areas

Civil Litigation Attorneys

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia, and Pennsylvania.

Are You an Affected Shareholder?

Faruqi & Faruqi, LLP is actively investigating the following cases:
24 Feb 2026
Navan, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI) and reminds investors of the April 24, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that the Offering Documents used to effectuate Navan’s IPO were false and misleading and omitted to state that, at the time of the offering, the Company had increased its “sales and marketing” expenses. Lead Plaintiff Deadline: April 24, 2026   Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
59 Days
Take Action
24 Feb 2026
Lakeland Industries, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE) and reminds investors of the April 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Throughout the Class Period, Defendants made materially false and misleading statements regarding Lakeland’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Lakeland was experiencing significant, sustained issues with its Pacific Helmets and Jolly businesses, including, inter alia, shipping-related delays, production issues, and slower than expected rollout of new products; (2) accordingly, Defendants overstated the anticipated and actual positive impact of these businesses on Lakeland’s financial results, as well as the overall strength and quality of  Pacific Helmets’ and Jolly’s respective operations; (3) Lakeland’s business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification delays, and material flow issues in its acquired businesses; (4) accordingly, Defendants overstated the strength of their tariff mitigation measures and SSQ M&A strategy; (5) as a result of all the foregoing issues, Defendants’ financial guidance was unreliable; and (6) as a result, Defendants’ public statements were materially false and misleading at all relevant times. Lead Plaintiff Deadline: April 24, 2026  Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
59 Days
Take Action
23 Feb 2026
Zynex, Inc.
If you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (OTCPK: ZYXIQ) and reminds investors of the April 21, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (a) Zynex shipped products, including electrodes, in excess of need; (b) as a result of this practice, the Company inflated its revenue; (c) the Company’s practice of filing false claims drew scrutiny from insurers, including Tricare; (d) on August 21, 2023, Travelers commenced an action against Zynex, Sandgaard, Lucsok and Fox in the Superior Court of California alleging that Zynex and the defendants had embarked on a fraudulent overbilling scheme and sought more than $23 million in damages and civil penalties relating to hundreds of fraudulent claims between 2018 and 2023; (e) management had prioritized aggressive sales strategies to drive orders over compliance with industry laws, rules and regulations; (f) the Company was not committed to maintaining a strong internal control environment; (g) the Company’s order growth was a result of illegal overbilling; (h) as a result, it was reasonably likely that Zynex would face adverse consequences, including removal from insurer networks and penalties from the federal government; and (i) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Lead Plaintiff Deadline: April 21, 2026  Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
56 Days
Take Action
19 Feb 2026
NuScale Power Corporation
If you purchased or acquired securities in NuScale between May 13, 2025 and November 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) and reminds investors of the April 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) ENTRA1 had never built, financed, or operated any significant projects – let alone projects in the highly technical and complicated field of nuclear power generation – during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NPMs and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by defendants during the class period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; and (4) as a result, NuScale’s commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks. Lead Plaintiff Deadline: April 20, 2026  Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) Or submit your information below to learn about your rights.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
55 Days
Take Action
Testimonials

Court Praises

Updates from Us

Latest News

See All
5 Dec 2025
The National Trial Lawyers Announces Zachary M. Winkler as a Member of the NTL – Civil Plaintiff – Top 40 Under 40 Trial Lawyers in Pennsylvania
Read More
4 Dec 2025
Faruqi & Faruqi, LLP Recertified by the Women’s Business Enterprise National Council
Read More
14 Nov 2025
Faruqi & Faruqi LLP Attorneys Recognized as Super Lawyers for 2025
Read More

From the Blog

See All
24 Feb 2026
BlackRock TCP and the spotlight on BDCs
Read More
23 Feb 2026
Ninth Circuit Revives Part of Investor Suit Against Funko, Inc.
Read More
20 Feb 2026
New York’s Trapped At Work Act: What It Means For Workers
Read More

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771